| Induced Sputum Collection in COPD Patients With and Without a Vibroacoustic Device (NCT07751705) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2026-08-18 |
| Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma (NCT06317909) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2024-08-09 |
| Biosensor and Environmental Sensor Development Within the REMEDIA Project (NCT06035276) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2023-08-28 |
| Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis (NCT05346718) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2022-09-01 |
| Impact of Carrier Solutions for House Dust Mite Allergen on Allergic Reactions (NCT05245175) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2022-02-22 |
| Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients (NCT05019209) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2021-09-10 |
| Use of Exhaled Particles to Assess Lung Pharmacokinetics (NCT04914273) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2021-06-14 |
| Second Follow-up Study of COPD Patients and Healthy Controls for Evaluation of Predictive Non-coding RNA Biomarkers (NCT04895124) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2021-05-25 |
| Quantification of Exhaled Particles to Identify Airborne Transmission Risks of COVID-19 (NCT04771585) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2021-03-29 |
| Effects of Spiolto® Respimat® (Tiotropium/Olodaterol) on Cardiac Function in Hyperinflated COPD Subjects (NCT04231214) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2020-01-28 |
| Effect of the Nasal Gel "Nascum®-Plus" on Allergic Symptoms (NCT03772405) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2018-12-12 |
| Characterization of the Inhibitory Effects of Fevipiprant (QAW039) on Activation of Eosinophils and ILC2 Cells by Prostaglandin D2 Metabolites (NCT03665701) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2018-08-16 |
| Pharmacokinetics of Enrofloxacin in Plasma and Urine (NCT03575312) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2018-04-27 |
| Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF) (NCT03524066) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2018-04-10 |
| Evaluation of Nasal Inflammatory Biomarkers (NCT03450031) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2018-02-08 |
| Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis (NCT03315611) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2017-10-02 |
| Investigation of Secreted Phosphoproteins and PiP3 (Phosphoinositolphospat 3) in Sputum (NCT03076086) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2017-05-12 |
| Development of Novel Non-invasive Inflammometry Following Lipopolysaccharide, Endotoxin (LPS) Challenge in Healthy Volunteers (NCT03044327) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2017-02-15 |
| Follow-up-study of COPD Patients and Healthy Controls for Evaluation of Predictive Non-coding RNA Biomarkers (NCT02522026) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2015-08-01 |
| Monocenter 6-period Study in Patients With Seasonal Allergic Rhinitis to Birch Pollen to Establish a Challenge Model With Natural Birch Pollen in an Environmental Challenge Chamber (ECC) (NCT01983865) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2013-11-01 |
| Effect of Pollen Challenges on Dermal Symptoms in Patients With Atopic Dermatitis (NCT01475994) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2011-11-01 |
| Suitability of a Low Dose Lipopolysaccharide (LPS) Inhalation as a Challenge Model (NCT01400568) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2011-08-01 |
| Ex Vivo Effect of Surfactant Protein D on Pulmonary Cells in Patients With Asthma and Pilot Study to Assess Local Inflammation Induced by Segmental Allergen Challenge by Magnetic Resonance Imaging (NCT01378624) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2011-06-01 |
| Validation of an Environmental Exposure Chamber for Inhalation Studies With House Dust Mite Allergen in Patients With Allergic Rhinitis (NCT01275456) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2011-01-01 |
| Pilot Study for Cell Based Therapies in Patients With Asthma (NCT01087515) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2010-03-01 |
| Characterization of Aerosol Generation and Transport in the Human Lung of Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01088633) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2010-03-01 |
| Characterization of Aerosol Generation and Transport in the Human Lung (NCT01095627) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2010-03-01 |
| Demonstration of Broncholytic Effects in Subjects With Obstructive Airway Diseases by Low Frequency Ultrasound (NCT01080924) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2010-02-01 |
| Influence of Diesel Exhaust Particles (DEP) With and Without Organic Compounds on the Allergic Inflammation in Asthmatic Subjects (NCT00773487) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2008-10-01 |
| Ex Vivo Effect of Surfactant Protein D on Pulmonary Immune Cells Derived From Bronchoalveolar Lavage After Segmental Allergen Challenge in Patients With Asthma (NCT00771992) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2008-10-01 |
| Novel Noninvasive Techniques to Study Neutrophil Airway Inflammation in an Ozone Challenge Model (NCT00743704) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2008-08-01 |
| Study to Explore the Effects of Two Hour Inhalation of Ultrafine Carbon Black Particles on Airway Inflammation in Asthmatics (NCT00527462) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2007-09-01 |
| Study to Compare the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Placebo on Symptoms in Patients With Allergic Rhinitis Within/Out of Season (NCT00474890) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2007-06-01 |
| Study to Assess the Effect of a Combination of Cetirizine With Pseudoephedrine Versus Cetirizine Alone on Symptoms in Patients With Allergic Rhinitis (NCT00334698) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2006-07-01 |
| A Pilot Monocenter Study to Assess Cellular and Soluble Biomarkers in Nasal Secretions (NCT00297843) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2006-03-01 |
| Effect of an Immunotoxin on Activated Human Macrophages in Those With Allergic Rhinitis or Mild Intermittent Asthma (NCT00295737) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2006-02-01 |
| The Role of Pollen Starch Granules in Pollen Challenge Studies in the Fraunhofer Environmental Exposure Unit (NCT00209365) | Fraunhofer-Institute of Toxicology and Experimental Medicine | 2005-09-01 |